10x Genomics Stock Price on November 21, 2024
| TXG Stock | USD 15.48 0.47 3.13% |
Below is the normalized historical share price chart for 10X Genomics extending back to September 12, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of 10X Genomics stands at 15.48, as last reported on the 29th of November, with the highest price reaching 15.72 and the lowest price hitting 15.22 during the day.
If you're considering investing in 10X Stock, it is important to understand the factors that can impact its price. 10X Genomics secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of risk over the last 3 months. 10X Genomics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm 10X Genomics' mean deviation of 3.02, and Variance of 20.36 to double-check the risk estimate we provide.
At this time, 10X Genomics' Stock Based Compensation To Revenue is most likely to increase slightly in the upcoming years. . At this time, 10X Genomics' Price To Sales Ratio is most likely to increase in the upcoming years. The 10X Genomics' current Price Sales Ratio is estimated to increase to 14.35, while Price Earnings Ratio is projected to decrease to (26.99). 10X Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of September 2019 | 200 Day MA 24.7341 | 50 Day MA 17.1824 | Beta 1.873 |
10X |
Sharpe Ratio = -0.1123
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TXG |
Estimated Market Risk
| 4.59 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.52 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average 10X Genomics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 10X Genomics by adding 10X Genomics to a well-diversified portfolio.
Price Book 2.5926 | Enterprise Value Ebitda (40.69) | Price Sales 2.9757 | Shares Float 105 M | Wall Street Target Price 20.2857 |
10X Genomics Main Headline on 21st of November 2024
Disposition of 1850 shares by Serge Saxonov of 10X Genomics ... by MacroaxisInsider
Filed transaction by 10X Genomics Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
10X Genomics Valuation on November 21, 2024
It is possible to determine the worth of 10X Genomics on a given historical date. On November 21, 2024 10X was worth 13.3 at the beginning of the trading date compared to the closed value of 13.29. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of 10X Genomics stock. Still, in general, we apply an absolute valuation method to find 10X Genomics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of 10X Genomics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against 10X Genomics' related companies.
| Open | High | Low | Close | Volume | |
| 13.61 | 13.80 | 13.16 | 13.32 | 1,406,059 | |
11/21/2024 | 13.30 | 13.51 | 13.02 | 13.29 | 1,625,962 |
| 13.17 | 14.57 | 12.98 | 14.31 | 5,631,022 |
| Backtest 10X Genomics | | | 10X Genomics History | | | 10X Genomics Valuation | Previous | Next |
10X Genomics Trading Date Momentum on November 21, 2024
| On November 22 2024 10X Genomics was traded for 14.31 at the closing time. Highest 10X Genomics's price during the trading hours was 14.57 and the lowest price during the day was 12.98 . The net volume was 5.6 M. The overall trading history on the 22nd of November contributed to the next trading period price rise. The trading price change to the next next day price was 7.67% . The daily price change to current price is 14.97% . |
10X Genomics Fundamentals Correlations and Trends
By evaluating 10X Genomics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among 10X Genomics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. 10X financial account trend analysis is a perfect complement when working with valuation or volatility modules.About 10X Genomics Stock history
10X Genomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for 10X is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in 10X Genomics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing 10X Genomics stock prices may prove useful in developing a viable investing in 10X Genomics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 117.2 M | 85.8 M | |
| Net Loss | -149.4 M | -156.9 M |
10X Genomics Quarterly Net Working Capital |
|
10X Genomics Stock Technical Analysis
10X Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
10X Genomics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
10X Genomics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
10X Genomics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how 10X Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading 10X Genomics shares will generate the highest return on investment. By undertsting and applying 10X Genomics stock market strength indicators, traders can identify 10X Genomics entry and exit signals to maximize returns
10X Genomics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for 10X Genomics' price direction in advance. Along with the technical and fundamental analysis of 10X Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of 10X to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.15) | |||
| Treynor Ratio | (0.32) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for 10X Stock analysis
When running 10X Genomics' price analysis, check to measure 10X Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X Genomics is operating at the current time. Most of 10X Genomics' value examination focuses on studying past and present price action to predict the probability of 10X Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X Genomics' price. Additionally, you may evaluate how the addition of 10X Genomics to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |